Osteoporosis News

ATLANTA — Romosozumab increases bone mineral density among patients with osteoporosis across different levels of renal function, according to a presenter at ACR/ARP 2019.

ATLANTA — Exercise is the one nonpharmacological intervention for which there is a strong recommendation in hip, knee, and hand osteoarthritis, according to a guideline update presented at ACR/ARP 2019.

ATLANTA — The 2019 iteration of the ACR/ARP Great Debate tackled the issue of whether anabolic therapies are appropriate for patients with glucocorticoid-induced osteoporosis.

Postmenopausal women who report sleeping less than 5 hours per night are more likely to develop low bone mineral density at all major sites and are at increased risk for osteoporosis at the hip and spine, according to findings published in the Journal of Bone and Mineral Research.

Elderly patients with atrial fibrillation who were prescribed direct oral anticoagulants had significantly lower risk for osteoporotic fractures than patients who were prescribed vitamin K antagonists such as warfarin, researchers reported.

SAN DIEGO — Taking a ‘holiday’ from many osteoporosis drugs can frequently negate gains in bone density, according to a presentation at the 2019 Congress of Clinical Rheumatology West.

The FDA on Monday approved an osteoporosis medication — PF708 — developed by Pfenex under the 505(b)(2) regulatory pathway as a follow-on biologic to teriparatide injection, according to a press release from the company.

SAN DIEGO — Acting on modifiable factors such as obesity and joint injury prevention could have a huge impact on osteoarthritis pathogenesis and incidence, according to a presentation at Congress of Clinical Rheumatology West.

For patients with osteoporosis, no drug treatment was associated with reduced mortality rates, according to a study published in JAMA Internal Medicine. These treatments should, therefore, only be recommended to decrease fracture risk.

Medication adherence for patients with rheumatoid arthritis, gout and osteoporosis was heavily influenced by the degree of trust patients had in their physician, as well as medication properties and patient capabilities, according to data published in Arthritis Care & Research.